← Back to patent-cliff list
CAS 696-23-1
2-Methyl-4(5)-nitroimidazole
Codes：Metronidazole hydrochloride-004
Application context (from source-drug indications)
十二指肠溃疡雷贝拉唑钠/甲硝唑/阿莫西林特发性血小板减少性紫癜雷贝拉唑钠/甲硝唑/阿莫西林胃溃疡雷贝拉唑钠/甲硝唑/阿莫西林胃炎雷贝拉唑钠/甲硝唑/阿莫西林幽门螺杆菌感染雷贝拉唑钠/甲硝唑/阿莫西林滴虫感染咪康唑/甲硝唑/利多卡因念珠菌病咪康唑/甲硝唑/利多卡因阴道炎咪康唑/甲硝唑/利多卡因
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 雷贝拉唑钠/甲硝唑/阿莫西林Rabeprazole Sodium/Metronidazole/Amoxicillin | Tier C — Watch / trade | - |
| 咪康唑/甲硝唑/利多卡因Miconazole/Metronidazole/Lidocaine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Glyoxal→Ethanal→2-Methylglyoxaline→2-Methyl-4(5)-nitroimidazole→Ethylene chlorohydrin→Ethyl nitrile→Methyl ethanimidoate hydrochloride→2,2-Dimethoxyethanamine→N-(2,2-Dimethoxyethyl)ethanimidamide
Glyoxal→Ethanal→2-Methylglyoxaline→2-Methyl-4(5)-nitroimidazole→Ethylene chlorohydrin→Ethyl nitrile→Methyl ethanimidoate hydrochloride→2,2-Dimethoxyethanamine→N-(2,2-Dimethoxyethyl)ethanimidamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.